These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24144609)

  • 1. Revisiting medication use in a frail 93-year-old man experiencing possible adverse effects.
    Farrell B; Monahan A; Thompson W
    CMAJ; 2014 Apr; 186(6):445-9. PubMed ID: 24144609
    [No Abstract]   [Full Text] [Related]  

  • 2. Polypharmacy: prevention and management.
    Tracy CS; Fuller J; Upshur RE
    CMAJ; 2014 Nov; 186(17):1321. PubMed ID: 25404652
    [No Abstract]   [Full Text] [Related]  

  • 3. Polypharmacy: prevention and management.
    Shamji S; Farrell B; Monahan A; Merkley VF
    CMAJ; 2014 Nov; 186(17):1321. PubMed ID: 25404653
    [No Abstract]   [Full Text] [Related]  

  • 4. Deprescribing: a new word to guide medication review.
    Frank C
    CMAJ; 2014 Apr; 186(6):407-8. PubMed ID: 24638028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polypharmacy and falls in the Elderly].
    Sommeregger U; Iglseder B; Böhmdorfer B; Benvenuti-Falger U; Dovjak P; Lechleitner M; Otto R; Roller RE; Gosch M
    Wien Med Wochenschr; 2010 Jun; 160(11-12):293-296. PubMed ID: 20640927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of enhanced pharmacologic care on the prevention of falls: a randomized controlled trial.
    Blalock SJ; Casteel C; Roth MT; Ferreri S; Demby KB; Shankar V
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):428-40. PubMed ID: 21335296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study.
    Wang R; Chen L; Fan L; Gao D; Liang Z; He J; Gong W; Gao L
    PLoS One; 2015; 10(11):e0142123. PubMed ID: 26554710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication prescribing in frail older people.
    Hubbard RE; O'Mahony MS; Woodhouse KW
    Eur J Clin Pharmacol; 2013 Mar; 69(3):319-26. PubMed ID: 22965651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.
    Bennett A; Gnjidic D; Gillett M; Carroll P; Matthews S; Johnell K; Fastbom J; Hilmer S
    Drugs Aging; 2014 Mar; 31(3):225-32. PubMed ID: 24452921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Falls in the elderly and drugs].
    von Renteln-Kruse W
    Z Gerontol Geriatr; 1997; 30(4):276-80. PubMed ID: 9410506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients.
    Poudel A; Peel NM; Nissen LM; Mitchell CA; Gray LC; Hubbard RE
    J Am Med Dir Assoc; 2016 Aug; 17(8):767.e9-767.e13. PubMed ID: 27373672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of inappropriate medications and balance: a study in a continuous care center.
    Takahashi PY; North F
    J Am Med Dir Assoc; 2007 Oct; 8(8):545. PubMed ID: 17931582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Discontinuing medication in elderly: a checklist may be useful].
    van Marum RJ
    Ned Tijdschr Geneeskd; 2011; 155(36):A3802. PubMed ID: 21914235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
    Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S
    J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria.
    Schuler J; Dückelmann C; Beindl W; Prinz E; Michalski T; Pichler M
    Wien Klin Wochenschr; 2008; 120(23-24):733-41. PubMed ID: 19122984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
    Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Waite L; Seibel MJ; McLachlan AJ; Cumming RG; Handelsman DJ; Le Couteur DG
    J Clin Epidemiol; 2012 Sep; 65(9):989-95. PubMed ID: 22742913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian and New Zealand Society for Geriatric Medicine: position statement - frailty in older people.
    Hubbard R; Ng K;
    Australas J Ageing; 2015 Mar; 34(1):68-73. PubMed ID: 25735472
    [No Abstract]   [Full Text] [Related]  

  • 20. [Focusing on polypharmacy in geriatrics].
    Gosch M; Pils K
    Z Gerontol Geriatr; 2012 Aug; 45(6):448-9. PubMed ID: 22806641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.